Skip to content
OpenCapital
Get started

Arvinas ARVN Market capitalization

Market capitalization at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$1.64B+40.1%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$6.8B+283%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$1.32B+361%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$730.04M+8,046%
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
$204.78M-10.4%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$1.02B+62.1%

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Enterprise value$439.41M-7.1%
P/S5.8×+4.5×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%—

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0×0.0×
Current ratio5.4×+0.9×

Where this comes from

Computed from the period-end share price: $677.99M.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arvinas's market capitalization?
Arvinas (ARVN) reported market capitalization of $677.99M in Q1 2026.
How has Arvinas's market capitalization changed year-over-year?
Arvinas's market capitalization increased by 40.4% year-over-year, from $482.78M to $677.99M.
What is the long-term trend for Arvinas's market capitalization?
Over 5 years (2020 to 2025), Arvinas's market capitalization has grown at a -29.9% compound annual growth rate (CAGR), from $4.49B to $761.7M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.